1. A Novel Homozygous LIPA Mutation in a Korean Child with Lysosomal Acid Lipase Deficiency
- Author
-
Gyeong Hoon Kang, Kyung Jae Lee, Eunhyang Park, Jin Soo Moon, Woo Sun Kim, Jae Sung Ko, Jung Min Ko, Ju Whi Kim, Young Hun Choi, and Kwang Yeon Kim
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Hepatosplenomegaly ,Case Report ,Lysosomal acid lipase deficiency ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Glycogen storage disease ,Dyslipidemias ,Hepatology ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,nutritional and metabolic diseases ,Enzyme replacement therapy ,medicine.disease ,Dried blood spot ,030104 developmental biology ,Endocrinology ,Liver biopsy ,Pediatrics, Perinatology and Child Health ,030211 gastroenterology & hepatology ,Differential diagnosis ,medicine.symptom ,business ,Lysosomes ,Dyslipidemia ,Hepatomegaly - Abstract
Patients with lysosomal acid lipase (LAL) deficiency and glycogen storage disease (GSD) demonstrated hepatomegaly and dyslipidemia. In our case, a 6-year-old boy presented with hepatosplenomegaly. At 3 years of age, GSD had been diagnosed by liver biopsy at another hospital. He showed elevated serum liver enzymes and dyslipidemia. Liver biopsy revealed diffuse microvesicular fatty changes in hepatocytes, septal fibrosis and foamy macrophages. Ultrastructural examination demonstrated numerous lysosomes that contained lipid material and intracytoplasmic cholesterol clefts. A dried blood spot test revealed markedly decreased activity of LAL. LIPA gene sequencing identified the presence of a novel homozygous mutation (p.Thr177Ile). The patient's elevated liver enzymes and dyslipidemia improved with enzyme replacement therapy. This is the first report of a Korean child with LAL deficiency, and our findings suggest that this condition should be considered in the differential diagnosis of children with hepatosplenomegaly and dyslipidemia.
- Published
- 2017